Treace Medical Concepts's top three insider shareholders as of March 23, 2026 are John T. Treace (Chief Executive Officer, 7.00Mn shares), Mark Hair (Chief Financial Officer, 863.55K shares), Scot Michael Elder (Chief Legl Comp Off, Corpsec, 794.94K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| John T. Treace | Chief Executive Officer | 7,004,550 | 0 | 11 Mar, 2026 |
| Mark Hair | Chief Financial Officer | 863,549 | 0 | 11 Mar, 2026 |
| Scot Michael Elder | Chief Legl Comp Off, Corpsec | 794,936 | 0 | 11 Mar, 2026 |
| Sean F. Scanlan | Chief Innovation Officer | 704,677 | 0 | 11 Mar, 2026 |
| Gaetano Guglielmino | Chief Commercial Officer | 490,901 | 0 | 23 Jan, 2026 |
| Joe W. Ferguson | Svp, Research Development | 419,756 | 0 | 08 Oct, 2021 |
| John T. Treace | Chief Executive Officer | 0 | 408,816 | 22 Oct, 2021 |
| Jaime A. Frias | See Remarks | 0 | 225,551 | 29 Apr, 2021 |
| Aaron Berutti | Svp, Sales | 205,092 | 0 | 12 Aug, 2025 |
| Joe W. Ferguson | Svp, Research Development | 0 | 85,575 | 29 Apr, 2021 |
| Deepti Jain | 70,243 | 0 | 21 May, 2025 | |
| Jaime A. Frias | Chief Legal Officer | 50,659 | 0 | 10 Mar, 2022 |
| Betsy Hanna | 45,243 | 0 | 21 May, 2025 | |
| Daniel E. Owens | 30,914 | 0 | 17 Mar, 2023 | |
| Terry W. Lubben | Svp, Operations | 5,850 | 0 | 10 Mar, 2022 |
| Mark Hair | Chief Financial Officer | 0 | 3,600 | 29 Apr, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 08 Mar, 2026 | Sean F. Scanlan | Common Stock | D | 401 | $0.00 | 706,073 | D | F |
| 08 Mar, 2026 | Mark Hair | Common Stock | D | 964 | $0.00 | 867,244 | D | F |
| 08 Mar, 2026 | John T. Treace | Common Stock | D | 2,062 | $0.00 | 7,009,571 | D | F |
| 08 Mar, 2026 | Scot Michael Elder | Common Stock | D | 175 | $0.00 | 796,611 | D | F |
| 10 Mar, 2026 | Sean F. Scanlan | Common Stock | D | 1,396 | $0.00 | 704,677 | D | F |
| 10 Mar, 2026 | Scot Michael Elder | Common Stock | D | 1,675 | $0.00 | 794,936 | D | F |
| 10 Mar, 2026 | John T. Treace | Common Stock | D | 5,021 | $0.00 | 7,004,550 | D | F |
| 10 Mar, 2026 | Mark Hair | Common Stock | D | 3,695 | $0.00 | 863,549 | D | F |
| 10 Feb, 2026 | Sean F. Scanlan | Common Stock | A | 16,875 | $1.05 | 706,474 | D | M |
| 10 Feb, 2026 | Sean F. Scanlan | Stock Option (Right to Buy) | D | 16,875 | $0.00 | 0 | D | M |
| 21 Jan, 2026 | Sean F. Scanlan | Common Stock | A | 53,500 | $0.72 | 427,099 | D | M |
| 22 Jan, 2026 | John T. Treace | Common Stock | D | 14,254 | $0.00 | 6,761,633 | D | F |
| 22 Jan, 2026 | Scot Michael Elder | Common Stock | D | 9,451 | $0.00 | 534,286 | D | F |
| 22 Jan, 2026 | Gaetano Guglielmino | Common Stock | A | 150,000 | $0.00 | 490,901 | D | A |
| 22 Jan, 2026 | Mark Hair | Common Stock | D | 17,037 | $0.00 | 493,208 | D | F |
| 22 Jan, 2026 | Scot Michael Elder | Common Stock | A | 262,500 | $0.00 | 796,786 | D | A |
| 22 Jan, 2026 | Sean F. Scanlan | Common Stock | A | 262,500 | $0.00 | 689,599 | D | A |
| 22 Jan, 2026 | Mark Hair | Common Stock | A | 375,000 | $0.00 | 868,208 | D | A |
| 22 Jan, 2026 | John T. Treace | Common Stock | A | 250,000 | $0.00 | 7,011,633 | D | A |
| 21 Jan, 2026 | Sean F. Scanlan | Stock Option (Right to Buy) | A | 53,500 | $0.00 | 0 | D | M |